Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene

Errata

This article corrects:

  1. Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene Volume 53, Issue 2, 587–595, Article first published online: 6 January 2011

In the February 2011 issue of Hepatology, in the article titled “Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene” (volume 53, pages 587-595; doi: 10.1002/hep.24040), by Shashikiran Donthamsetty, Vishakha S. Bhave, Corrine S. Kliment, William C. Bowen, Wendy M. Mars, Aaron W. Bell, Rachel E. Stewart, Anne Orr, Chuanyue Wu and George K. Michalopoulos, the upper left photomicrograph of Fig. 4D, showing Myc expression in nonhepatectomized wild-type mice, was erroneously taken from the liver of a nonhepatectomized ILK knockout mouse. The following image is derived from wild-type mice and corrects the image published in the original article.

image

The publisher regrets the error.

Ancillary